Ephedra Bill Likely To Be Subject Of Hearing Within The Next Month
This article was originally published in The Tan Sheet
Executive Summary
A hearing on the "Ephedra Public Protection Act" (HR 1075), which would ban the sale of all ephedrine alkaloid-containing dietary supplements under certain conditions, is expected within the next month
You may also be interested in...
Supplement Bill Increasing FDA Access To Safety Data Planned By Waxman
Reps. Henry Waxman (D-Calif.) and Susan Davis (D-Calif.) are working on legislation "that will give FDA greater access to information to understand if a [dietary supplement] product does pose a health risk and will let FDA protect consumers from unsafe products," Waxman said at a July 23 hearing of the House Energy & Commerce/Oversight & Investigations Subcommittee
Supplement Bill Increasing FDA Access To Safety Data Planned By Waxman
Reps. Henry Waxman (D-Calif.) and Susan Davis (D-Calif.) are working on legislation "that will give FDA greater access to information to understand if a [dietary supplement] product does pose a health risk and will let FDA protect consumers from unsafe products," Waxman said at a July 23 hearing of the House Energy & Commerce/Oversight & Investigations Subcommittee
Supplement Bill Increasing FDA Access To Safety Data Planned By Waxman
Reps. Henry Waxman (D-Calif.) and Susan Davis (D-Calif.) are working on legislation "that will give FDA greater access to information to understand if a [dietary supplement] product does pose a health risk and will let FDA protect consumers from unsafe products," Waxman said at a July 23 hearing of the House Energy & Commerce/Oversight & Investigations Subcommittee